icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2021
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of the siRNA JNJ-3989 and/or
the Capsid Assembly Modulator JNJ-6379 for the
Treatment of Chronic Hepatitis B Virus Infection :
Results From the Phase 2b REEF-1 Study

 
 
  AASLD 2021 Nov 12-15
 
Man-Fung Yuen,1 Tarik Asselah,2 Ira M. Jacobson,3 Maurizia Brunetto,4 Harry L.A. Janssen,5 Tetsuo Takehara,6 Jin Lin Hou,7 Thomas N. Kakuda,8 Tom Lambrecht,8 Maria Beumont,8 Ronald Kalmeijer,8 Carine Guinard-Azadian,8 Cristiana Mayer,8 John Jezorwski,8 Thierry Verbinnen,8 Oliver Lenz,8 Umesh Shukla,8 Michael Biermer8

1215211

1215212

1215213

1215214

1215215

1215216

1215217